Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holtmann

Showing results (491-500 of 1,259) with videos related to

Pageof 126
Sort By:
Alimentary Pharmacology & Therapeutics|August 16, 2005
Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsiaB Adam, T Liebregts, K Saadat-Gilani, et al.
The New England Journal of Medicine|February 24, 2006
A placebo-controlled trial of itopride in functional dyspepsiaGerald Holtmann, Nicholas J Talley, Tobias Liebregts, et al.
Journal of Gastroenterology|January 12, 2013
Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndromeBirgit Adam, Chris Tsopelas, Tobias Liebregts, et al.
Zeitschrift Fur Gastroenterologie|September 26, 2002
Functional relevance of soluble TNF-alpha, transmembrane TNF-alpha and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseasesM H Holtmann, M Schütz, P R Galle, et al.
Journal of Neurobiology|November 1, 1994
Ciliary neurotrophic factorM Sendtner, P Carroll, B Holtmann, et al.
Nature|December 24, 1992
Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve sectionM Sendtner, B Holtmann, R Kolbeck, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2009
Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mgA Eggleston, P H Katelaris, S Nandurkar, et al.
Inflammatory Bowel Diseases|December 20, 2011
An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementationAntonina A Mikocka-Walus, Deborah Turnbull, Gerald Holtmann, et al.
Head & Face Medicine|January 6, 2016
Orbital floor fractures--short- and intermediate-term complications depending on treatment proceduresHenrik Holtmann, Hatice Eren, Karoline Sander, et al.
Biotechnology and Bioengineering|November 18, 2015
A simplified process design for P450 driven hydroxylation based on surface displayed enzymesFrank W Ströhle, Eva Kranen, Jens Schrader, et al.
Pageof 126

Showing results (491-500 of 1,259) with videos related to

Sort By:
Pageof 126
Alimentary Pharmacology & Therapeutics|August 16, 2005
Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsiaB Adam, T Liebregts, K Saadat-Gilani, et al.
The New England Journal of Medicine|February 24, 2006
A placebo-controlled trial of itopride in functional dyspepsiaGerald Holtmann, Nicholas J Talley, Tobias Liebregts, et al.
Journal of Gastroenterology|January 12, 2013
Host immune response determines visceral hyperalgesia in a rat model of post-inflammatory irritable bowel syndromeBirgit Adam, Chris Tsopelas, Tobias Liebregts, et al.
Zeitschrift Fur Gastroenterologie|September 26, 2002
Functional relevance of soluble TNF-alpha, transmembrane TNF-alpha and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseasesM H Holtmann, M Schütz, P R Galle, et al.
Journal of Neurobiology|November 1, 1994
Ciliary neurotrophic factorM Sendtner, P Carroll, B Holtmann, et al.
Nature|December 24, 1992
Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve sectionM Sendtner, B Holtmann, R Kolbeck, et al.
Alimentary Pharmacology & Therapeutics|February 13, 2009
Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care--prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mgA Eggleston, P H Katelaris, S Nandurkar, et al.
Inflammatory Bowel Diseases|December 20, 2011
An integrated model of care for inflammatory bowel disease sufferers in Australia: development and the effects of its implementationAntonina A Mikocka-Walus, Deborah Turnbull, Gerald Holtmann, et al.
Head & Face Medicine|January 6, 2016
Orbital floor fractures--short- and intermediate-term complications depending on treatment proceduresHenrik Holtmann, Hatice Eren, Karoline Sander, et al.
Biotechnology and Bioengineering|November 18, 2015
A simplified process design for P450 driven hydroxylation based on surface displayed enzymesFrank W Ströhle, Eva Kranen, Jens Schrader, et al.
Pageof 126